William Ho

Directeur Technique/Scientifique/R&D chez RAPT THERAPEUTICS, INC.

Fortune : 122 772 $ au 30/04/2024

58 ans

Health Technology

Consumer Services

Postes actifs de William Ho

Sociétés	Poste	Début	Fin
RAPT THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	01/05/2015	-

Sociétés	Poste	Début	Fin
Igenica Biotherapeutics, Inc. Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA.	Corporate Officer/Principal	01/10/2012	01/06/2016
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Directeur Technique/Scientifique/R&D	01/09/2005	01/09/2012

Princeton University	Undergraduate Degree
Stanford University School of Medicine	Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Sectorielle

Health Technology	4
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
RAPT THERAPEUTICS, INC.	Health Technology

Entreprise privées	2
Igenica Biotherapeutics, Inc. Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Entreprise privées

Health Technology